"Progressive Necrotizing Diseases; Management:Titrated Dosage Anti-Histaminics Role."

Journal Title: IOSR Journal of Pharmacy (IOSRPHR) - Year 2017, Vol 7, Issue 11

Abstract

ABSTRACT: Introduction- Amongst Various Skin & Soft Tissue Infection(SSTI),Progressive Necrotizing Disease(PND): Infections, Cellulititis, Fascitis(NF) & Sometimes Myositis, Is Not Uncommon Clinical Entity, Characterized By Extensive, Rapidly Progressive Soft-Tissue Necrosis That Usually Involves The Subcutaneous Tissue And Muscular Fascia, But Can Also Affect The Skin And Muscle, Has Vivid Spectrum Of Epidemiolgical, Aetio-Pathogenesis, Clinical Manifestations Of Varying Severity & Differing Treatment Seeking TimePeriod. NF Poses A Serious Surgical Challenge Not Only Because Of Its Rapid And Progressive Nature, But Also Because Of Its Attributing High Morbidity And Mortality. Materials & Method- Present Multi-Centric Study, Comprising About 500 Patients Presenting With Variable Stages Of Disease, Performed At, Plains Of North India Haryana, Adjoinig Rajasthan & Hilly Region Of Uttarakhand, During Last More Than A Decade Duration. Management Methodology-Management Of Pre-Existing & Or Precipitating Co-Morbidities - Diabetes, HTN, Deranged Renal Function, C-Reactive Protiens, HB%, Serum Protiens, Electrolytes, Minerals, Blood Gas Chemistry Alterations, Hepatic Dysfunction, Different Stages Of Progressive Toxicaemia, Septicaemia Due To Ensuing ‘PF Shock Syndrome’, Time Of Seeking Medical Attention & Standard Of Appropriate Care, Are Important Determinants For OverAll Result Out Come, In Regards To Mortality & Morbidity Aspects. Results-Early (Immediately/Within 2-4 Days Of Disease Onset), Medical Opinion Seeking Patients, Managed With, Described Medical Therapy Including Anti-Allergic Drug, For 3-5-7 Days, With Careful Monitoring & As Needed Immediate Follow Up Advise, Were Completely Relieved, In About 75% Of The Cases, (i.e Disease Process Cessation Control, In Clinical Stage -1(Early) & Upto Initial Clinical Stage- 2, In Early Reporting Category Patients). Remaining About 25% Patients, Not Completely Controlled By Described Treatment Protocol & Late Presentations Of 1-2 Weeks Disease Onset With Progressive Disease Of Varying Manifestations, Responded To Management-Medical, Surgical, Supportive & Could Be Discharged Within 1-2 Weeks Of Hospital Stay. About 5-10% Patients-Late Presentations Of Severe Progressive Disease,Without Previous Treatment & Or Not Proper Inadequate Management, In Different Stages Of Septicaemia, Deteriorating G.C, Co-Existing Controlled/ Uncontrolled Co-Morbidities, Were Advised Referral To Higher Specialized Centres For Immunotherapy, Hyper-Baric Oxygen Therapy Etc. After Preliminary Management & Supportive Measures With Ensured Safe, Secure Transport, Otherwise, Continued Management At The Same Centre, With Prognosis Explained Treatment Risk Consent, Recorded Increased Morbidity And About 1-2% Mortality. Conclusion- In Clinical Stage -1(Early) & Upto Initial Clinical Stage-2(Intermediate), Reporting Early To Clinician Category Patients,(i.e Clinically Evident Acute Inflammatory Response Phase – Usually, Initial 3-5-7 Days After Disease Process Onset, In All Types), Inclusion Of Meticulously Titrated Dosage Duration Schedule Of Anti-Allergic Medication Therapy, In Administered Medications, With Properly Instituted Supportive Measures, Controlled Necrotizing Soft-Tissue Disease Process Severity, Conversion To Next Clinico-Pathological Strata Of Disease (Infections-CellulitisFascitis-Myositis & Others.), Associated Complications, Sequelae Of The Disease Process, Safely, With Better Result Out Comes Of Subsequent Management & Decreased Morbidity, Mortality.

Authors and Affiliations

Dr. (Prof. ) Anil K. Sahni

Keywords

Related Articles

 Human cataract prevalence in Thiruvananthapuram district of Kerala state

 Aim:-Hospital based study from April 2005 to March 2011 conducted among the population to determine the prevalence of cataract in Thiruvananthapuram district of Kerala state of India. Methodology:-The data’s colle...

 Determining the Phytochemical Constituents and the Antimicrobial Activity of Ethanolic Extract of Acassia Leaf (Senna Siamea) On Some Enterobacteriaceae

 ABSTRACT: Microorganisms are known to cause different types of infection in both humans and animals. The use of medicinal plants to prevent and treat such infections is increasing. This study was aimed at&nbsp...

 Stroke: A Brain Attack

 : There are 15 million people worldwide who suffer a stroke each year. According to the World Health Organization (WHO), stroke is the second leading cause of death for people above the age of 60 years, and the f...

"Progressive Necrotizing Diseases; Management:Titrated Dosage Anti-Histaminics Role."

ABSTRACT: Introduction- Amongst Various Skin & Soft Tissue Infection(SSTI),Progressive Necrotizing Disease(PND): Infections, Cellulititis, Fascitis(NF) & Sometimes Myositis, Is Not Uncommon Clinical Entity, Characterized...

Download PDF file
  • EP ID EP253688
  • DOI -
  • Views 111
  • Downloads 0

How To Cite

Dr. (Prof. ) Anil K. Sahni (2017). "Progressive Necrotizing Diseases; Management:Titrated Dosage Anti-Histaminics Role.". IOSR Journal of Pharmacy (IOSRPHR), 7(11), 60-68. https://europub.co.uk/articles/-A-253688